Developing a cardiac patch consisting of healthy heart cells that have come from the patient's own stem cells to repair damaged areas of the heart muscle, following a heart attack.
Drug discovery / Therapeutics
During a heart attack, muscles in the heart can become damaged. This can cause long-term difficulty pumping blood around the body making reoccurrence of a heart attack more likely and can ultimately lead to heart failure.
The aim of this project is to create a cardiac patch which can support the areas of the heart affected by the heart attack. The patch will act as a mechanical restraint for the failing heart and be a source of healthy heart muscle cells that will replace the damaged cells of the heart. The cells delivered via this patch will be healthy heart cells obtained using specific type of stem cells: induced pluripotent stem cells (iPSCs). These cells can become any cell type in the body including the cells that make up the muscles of the heart. They can be made by converting skin cells into stem cells in the lab. Using the patient’s own skin will ensure that the cells will be accepted by the body, preventing any immune reaction, and eliminating the need for the anti-rejection drugs involved in many heart operations.
Once the heart is repaired, the material will break down in the body over time. This means heart function can be restored without the need of a permanent implant or a secondary operation to remove the patch once the heart has healed.
These patches have previously demonstrated the ability to support tissue regeneration and repair. A similar patch was produced in Professor Roy’s lab and showed great potential as a treatment for heart attacks, but some modifications are still needed. The previous patch degraded too slowly, so it could not encourage enough heart cells to transfer to the heart from the patch. This will be tackled in this study by combining the previous material with another faster degrading material.
This project will therefore aim to improve the effectiveness of this patch and test it again so that the team can move towards clinical trials in the future. This patch has a huge potential to improve survival and healthy living post heart attack.
The development of a new AI-supported model for imaging the heart based on data from over 700 people with atrial fibrillation, allow ablation to be more personalised to individual patients.
A trial for every patient
Personalised angina care
Blood clots in acute coronary syndrome
Your gifts fund our life saving project